Вы искали: spinocellulært (Датский - Английский)

spinocellulært carcinom
spinalioma

papillomatøst spinocellulært karcinom
papillary cutaneous carcinoma

cellekarcinom og spinocellulært karcinom),
system organ class

blandet baso- og spinocellulært karcinom
mixed baso-and spinocellular carcinoma

d.m.b.a.-spinocellulært carcinom
d.m.b.a.fusocellular sarcoma

celle-karcinom og spinocellulært karcinom)
basal cell carcinoma and squamous cell

ise ovarie og testikler) , spinocellulært karcinom
lymphoma, solid organ tumours (including breast, ovarian, testicular) , squamous cell carcinoma of the skin

minor keratoakantom/spinocellulært karcinom i huden
minorkeratoacanthoma/

ikke almindelig basalcellekarcinom og spinocellulært karcinom, hudpapillom
uncommon basal cell and squamous cell carcinoma, skin papilloma

7 kaposisarkom, lymfom, spinocellulært karcinom, hepatocellulært karcinom samt analcancer.
the cancers included kaposi 's sarcoma, lymphoma, squamous cell carcinoma, hepatocellular carcinoma and anal cancer.

cancerformerne omfattede kaposisarkom, lymfom, spinocellulært karcinom, hepatocellulært karcinom samt analcancer.
the cancers included kaposi’ s sarcoma, lymphoma, squamous cell carcinoma, hepatocellular carcinoma and anal cancer.

lymfomer, faste organtumorer (herunder i bryst, ovarie og testikler), spinocellulært karcinom
lymphoma, solid organ tumours (including breast, ovarian, testicular), squamous cell carcinoma of the skin

lymfomer, faste organtumorer (herunder i bryst, ovarie og testikler), malignt melanom, spinocellulært karcinom
lymphoma, solid organ tumours (including breast, ovarian, testicular), malignant melanoma, squamous cell carcinoma of the skin

i et klinisk forsøg med 147 patienter med fremskredent spinocellulært carcinom på hoved og hals blev tumorrespons, defineret som en reduktion af mindst 50 % af tumormassen i mindst fire uger, observeret hos 25 % af patienterne efter en enkelt behandling.
in a clinical trial of 147 patients with advanced head and neck squamous cell carcinoma, tumour response, defined as a reduction of a minimum of 50 % of the tumour mass for a minimum of four weeks, was observed in 25 % after a single treatment.